Mortality
Page highlight
In 2024, chronic kidney disease contributed to around 21,300 deaths in Australia – 11% of all deaths.
Chronic kidney disease (CKD) may be listed as the underlying cause of death – or, more commonly, as an associated cause – on a death certificate where another condition is listed as the underlying cause.
In 2024, CKD contributed to around 21,300 deaths in Australia, 11% of all deaths (underlying or associated).
Of these, CKD was listed as an underlying cause of death in around 5,100 cases (24% of all CKD deaths). It was recorded as an associated cause in a further 16,200 deaths (around 76% of CKD deaths).
Linked data from the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry and National Death Index has shown that CKD, particularly kidney failure, is often an under-reported cause of death (AIHW 2016).
Diseases commonly listed as underlying causes of death where chronic kidney disease is an associated cause
In cases where CKD was an associated cause of death, the most common underlying causes were:
- Coronary heart disease (I20–I25) (14%)
- Dementia including Alzheimer's disease (F01, F03, G30) (7.6%)
- Diabetes (E10–E14) (7.0%)
- Heart failure and complications and ill-defined heart disease (I50–I51) (4.5%)
- Chronic obstructive pulmonary disease (COPD) (J40–J44) (4.2%).
In cases where CKD was the underlying cause of death, the most common associated causes included:
- Heart failure and complications and ill-defined heart disease (I50–I51) (27%)
- Other ill-defined causes (R00–R94, R96–R99, I46.9, I95.9, I99, J96.0, J96.9, P28.5) (26%)
- Diabetes (E10–E14) (24%)
- Hypertensive disease (I10–I15) (22%)
- Coronary heart disease (I20–I25) (14%).
Note: multiple associated causes can be listed for a death. Causes of death are grouped in this analysis using the recommendations of the World Health Organization (WHO) (Becker et al. 2006) with minor modifications to suit the Australian context. For more information, see Deaths in Australia.
Trends over time
The number of deaths with CKD as an underlying or associated cause doubled between 2000 and 2024 (10,200 and 21,300 deaths). After accounting for changes in the age structure of the population over this time, the rate of CKD deaths remained relatively stable between 2000 and 2024. The CKD death rate for females was consistently lower than for males.
CKD mortality rates increased slightly year-on-year in both 2021 and 2022 (4.4% and 6.3%, respectively), after adjusting for age, before falling back to the prior rate in 2024 (Figure 1). These increases should be interpreted in the context of higher overall mortality in 2022, with two-thirds of excess deaths being associated with COVID-19 (ABS 2023).
For more information on the impact of COVID-19, see COVID-19 and chronic kidney disease: Impacts in Australia, 2020–2022
Figure 1: Trends in chronic kidney disease death rates (underlying or associated cause), by sex, 2000 to 2024
The age-standardised rate of chronic kidney disease deaths remained stable between 2000 and 2024 at 55 to 60 deaths per 100,000 population
| Year | Male | Female | Persons |
|---|---|---|---|
| 2000 | 72.6 | 43.3 | 54.7 |
| 2001 | 73.6 | 43.1 | 54.9 |
| 2002 | 77.3 | 44.0 | 57.0 |
| 2003 | 78.1 | 43.7 | 57.2 |
| 2004 | 78.3 | 44.0 | 57.4 |
| 2005 | 74.2 | 43.1 | 55.4 |
| 2006 | 79.0 | 44.6 | 58.3 |
| 2007 | 75.3 | 45.5 | 57.6 |
| 2008 | 80.2 | 48.3 | 61.2 |
| 2009 | 74.7 | 45.8 | 57.7 |
| 2010 | 72.6 | 44.5 | 56.2 |
| 2011 | 73.6 | 44.1 | 56.2 |
| 2012 | 72.6 | 44.6 | 56.3 |
| 2013 | 73.0 | 45.0 | 56.8 |
| 2014 | 72.3 | 46.0 | 57.2 |
| 2015 | 72.6 | 46.7 | 57.8 |
| 2016 | 73.1 | 47.6 | 58.6 |
| 2017 | 72.7 | 48.0 | 58.8 |
| 2018 | 69.5 | 44.2 | 55.3 |
| 2019 | 69.1 | 45.4 | 55.9 |
| 2020 | 67.6 | 44.2 | 54.5 |
| 2021 | 70.2 | 46.2 | 56.9 |
| 2022 | 74.4 | 49.1 | 60.5 |
| 2023 | 69.5 | 45.4 | 56.2 |
| 2024 | 67.2 | 45.5 | 55.3 |
Notes
- Age-standardised to the 2001 Australian Standard Population.
- Deaths are counted according to year of registration of death.
- Deaths registered in 2021 and earlier are based on the final version of cause of death data; deaths registered in 2022 are based on the revised version; and deaths registered in 2023 and 2024 are based on the preliminary version. Revised and preliminary versions are subject to further revision by the Australian Bureau of Statistics (ABS).
Source:
AIHW National Mortality Database
Variation by age and sex
In 2024, death rates for CKD as an underlying or associated cause:
- were 1.5 times higher in males than in females, after adjusting for age
- were higher in males than females across all age groups
- increased with age, with substantially higher rates among those aged 85 and over. This age group accounted for 51% of all deaths due to CKD in 2024 and had an age specific death rate that was 4.7 times as high as for people aged 75–84 (1,900 and 393 deaths per 100,000 population) (Figure 2).
Figure 2: Chronic kidney disease death rates (underlying or associated cause), by age and sex, 2024
In 2024, chronic kidney disease death rates were highest for males aged 85 and over
| Age group | Male | Female | Persons |
|---|---|---|---|
| 0–54 | 3.9 | 2.5 | 3.2 |
| 55–64 | 42.4 | 25.2 | 33.6 |
| 65–74 | 131.4 | 74.2 | 101.6 |
| 75–84 | 486.5 | 309.9 | 393.2 |
| 85+ | 2,176.1 | 1,659.8 | 1,867.0 |
Notes
- Deaths are counted according to year of registration of death.
- Deaths registered in 2024 are based on preliminary data and are subject to further revision by the Australian Bureau of Statistics.
Source:
AIHW National Mortality Database
Variation by priority population groups
In 2024, the age-standardised death rate for CKD (as an underlying or associated cause of death) was higher in Remote and very remote areas and in areas with increased socioeconomic disadvantage.
After adjusting for differences in the age structure of the population groups:
- the death rates in Remote and very remote areas were 2.4 times as high as in Major cities. This difference was greater for females than males (2.7 times as high for females and 2.1 times as high for males).
- death rates were 1.8 times as high in the lowest socioeconomic area than in the highest socioeconomic area (Figure 3).
For information for Aboriginal and Torres Strait Islander (First Nations) people, see First Nations People.
Figure 3: Chronic kidney disease death rates (underlying or associated cause), by population group, 2024
| Remoteness area | Male | Female | Persons |
|---|---|---|---|
| Major cities | 63.5 | 41.5 | 51.3 |
| Inner regional | 67.5 | 48.0 | 57.1 |
| Outer regional | 77.8 | 59.0 | 67.9 |
| Remote and very remote | 133.8 | 110.2 | 121.8 |
| Socioeconomic group | Male | Female | Persons |
|---|---|---|---|
| Group 1 (most disadvantaged) | 86.6 | 62.4 | 73.4 |
| Group 2 | 72.7 | 50.4 | 60.6 |
| Group 3 | 64.7 | 42.0 | 52.3 |
| Group 4 | 58.5 | 38.4 | 47.4 |
| Group 5 (least disadvantaged) | 49.7 | 32.2 | 39.9 |
Notes
- Age-standardised to the 2001 Australian Standard Population.
- Excludes persons where remoteness area and/or socioeconomic area was missing.
- Remoteness is classified according to the Australian Statistical Geography Standard 2021 Remoteness Areas structure based on Statistical Area Level 2 (SA2) of usual residence.
- Socioeconomic groups are classified according to population-based quintiles using the Index of Relative Socio-Economic Disadvantage based on 2021 ASGS Statistical Area Level 2 (SA2) of usual residence.
- Deaths registered in 2024 are based on preliminary data and are subject to further revision by the Australian Bureau of Statistics.
Source:
AIHW National Mortality Database
ABS (Australian Bureau of Statistics) (2023) Measuring Australia's excess mortality during the COVID-19 pandemic until August 2023, ABS, Australian Government, accessed 16 May 2024.
AIHW (Australian Institute of Health and Welfare) (2016) Incidence of end-stage kidney disease in Australia 1997–2013, catalogue number PHE 211, AIHW, Australian Government, accessed 7 February 2021.
Becker R, Silvi J, Ma Fat D, L’Hours A and Laurenti R (2006) 'A method for deriving leading causes of death', Bulletin of the World Health Organization, 84:297–304.
Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G and Massy ZA (2013) ‘Cognitive disorders and dementia in CKD: the neglected kidney–brain axis’, Journal of the American Society of Nephrology, 24(3):353–363, doi:10.1681/ASN.2012050536.